Current through Register Vol. 56, No. 21, November 4, 2024
Section 10A:16-15.2 - Distribution of and instructions for inmate use of KOP medication(a) Prior to distributing a KOP medication to an inmate, the responsible health authority shall determine whether the inmate has the necessary stability, ability, and skill to handle independent self-administration of the medication and make a recommendation to the Administrator or designee. When independent, self-administration of the medication is disapproved, the reason(s) shall be documented in the EHR by the responsible health authority or designee.(b) KOP medication shall be packaged with information to include, but not be limited to: 1. The name and number of the inmate;3. The method of administration;8. Directions for taking the medication; and9. The name of the responsible health authority who ordered the medication.(c) The health care provider shall ensure verbal instructions regarding the KOP medication are provided to each inmate authorized to possess and independently self-administer the medication. Instructions shall include, but not be limited to, the following: 1. The name, method of administration, dosage, and directions for taking the medication;2. The intended use of the medication;3. Possible side effects and instructions for reporting any side effects;5. Refill procedures (if appropriate) and handling of any unused KOP medication; and6. Rules and internal management procedures regarding KOP medication and the responsibility of the inmate to fully comply. N.J. Admin. Code § 10A:16-15.2
Amended by 49 N.J.R. 2800(a), effective 8/21/2017